PFG Advisors
Position in CRL — Charles River Laboratories International, Inc.
CIK 1694435
Phoenix, AZ
Position in CRL
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$537,719
+$130,964 QoQ
Shares Held
2,371
+0.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#299
of 564 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PFG Advisors holds $7,982,517 across 5 Diagnostics & Research names. CRL ranks #4 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
19,699 | $3,752,265 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
5,172 | $2,722,747 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
3,771 | $728,632 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
This page
|
2,371 | $537,719 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
481 | $241,154 |
All Filings in CRL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $537,719 | 2,371 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $406,755 | 2,358 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $472,568 | 2,369 | Shares | Sole | 2026-01-27 | |
| 2022-09-30 | $207,624 | 1,055 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $237,506 | 1,110 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $335,084 | 1,180 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,209,463 | 3,210 | Shares | Sole | 2022-01-21 | |
| No filing history on record for this holder in this stock. | ||||||